AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.90+3.70 (+3.48%) ▲|ACN262.81+4.57 (+1.77%) ▲|ADBE255.00+4.77 (+1.91%) ▲|AMAT387.78-2.31 (-0.59%) ▼|AMD483.88-20.93 (-4.15%) ▼|AMGN466.59+0.58 (+0.12%) ▲|AMT188.18+0.40 (+0.21%) ▲|AMZN250.14+9.79 (+4.07%) ▲|AVGO329.94+3.86 (+1.18%) ▲|AXP328.87+9.76 (+3.06%) ▲|BA175.65+4.10 (+2.39%) ▲|BAC50.24+0.23 (+0.46%) ▲|BKNG155.04+6.91 (+4.66%) ▲|BLK1,174.62+27.08 (+2.36%) ▲|BMY62.46-0.02 (-0.03%) ▼|BNY148.30+1.19 (+0.81%) ▲|BRK-B554.76+12.27 (+2.26%) ▲|C123.82+1.85 (+1.52%) ▲|CAT623.25+0.50 (+0.08%) ▲|CL96.99+1.70 (+1.78%) ▲|CMCSA23.75+0.53 (+2.28%) ▲|COF212.07+7.22 (+3.52%) ▲|COP147.31-6.72 (-4.36%) ▼|COST1,039.22+26.94 (+2.66%) ▲|CRM232.27+3.10 (+1.35%) ▲|CSCO103.19-1.32 (-1.26%) ▼|CVS88.53-1.73 (-1.91%) ▼|CVX228.15-7.37 (-3.13%) ▼|DE664.40-11.08 (-1.64%) ▼|DHR229.50-2.73 (-1.18%) ▼|DIS113.60+2.66 (+2.40%) ▲|DUK127.93+0.54 (+0.42%) ▲|EMR168.41+3.47 (+2.10%) ▲|FDX319.72+6.44 (+2.06%) ▲|GD369.31-3.29 (-0.88%) ▼|GE315.95+14.15 (+4.69%) ▲|GEV877.20+19.33 (+2.25%) ▲|GILD170.19-0.49 (-0.29%) ▼|GM89.40+2.00 (+2.28%) ▲|GOOG281.97+3.75 (+1.35%) ▲|GOOGL283.48+3.64 (+1.30%) ▲|GS909.74+15.19 (+1.70%) ▲|HD339.46+10.26 (+3.12%) ▲|HON225.16+6.83 (+3.13%) ▲|IBM258.34+0.53 (+0.21%) ▲|INTC61.96-3.81 (-5.79%) ▼|INTU355.56+14.47 (+4.24%) ▲|ISRG444.94+12.93 (+2.99%) ▲|JNJ269.26-3.94 (-1.44%) ▼|JPM341.71+4.67 (+1.38%) ▲|KO95.69+1.61 (+1.71%) ▲|LIN521.96+7.72 (+1.50%) ▲|LLY1,412.61-4.93 (-0.35%) ▼|LMT641.11+4.16 (+0.65%) ▲|LOW216.26+7.19 (+3.44%) ▲|LRCX232.86-6.25 (-2.61%) ▼|MA659.63+21.62 (+3.39%) ▲|MCD263.87+5.75 (+2.23%) ▲|MDLZ66.05+1.11 (+1.70%) ▲|MDT98.69+2.15 (+2.23%) ▲|META612.09-2.90 (-0.47%) ▼|MMM179.35+5.01 (+2.87%) ▲|MO77.51-0.52 (-0.67%) ▼|MRK148.53-0.99 (-0.66%) ▼|MS186.52+2.22 (+1.20%) ▲|MSFT520.02-1.90 (-0.36%) ▼|MU852.74-32.00 (-3.62%) ▼|NEE84.99+1.28 (+1.52%) ▲|NFLX62.60+0.52 (+0.84%) ▲|NKE39.53+0.86 (+2.22%) ▲|NOW108.78+3.66 (+3.48%) ▲|NVDA206.58+1.94 (+0.95%) ▲|ORCL122.29-8.38 (-6.41%) ▼|PEP140.01+2.67 (+1.94%) ▲|PFE30.71+0.19 (+0.61%) ▲|PG163.79+2.22 (+1.37%) ▲|PLTR184.31+0.20 (+0.11%) ▲|PM208.04-0.75 (-0.36%) ▼|QCOM166.20+1.41 (+0.86%) ▲|RTX201.84+2.04 (+1.02%) ▲|SBUX103.86+0.21 (+0.20%) ▲|SCHW89.25+1.20 (+1.36%) ▲|SO94.31+0.60 (+0.64%) ▲|SPG222.83+5.08 (+2.33%) ▲|T21.44+0.03 (+0.14%) ▲|TMO685.44-11.56 (-1.66%) ▼|TMUS158.56+2.12 (+1.36%) ▲|TSLA408.55+8.74 (+2.18%) ▲|TXN308.30+7.46 (+2.48%) ▲|UBER67.19+1.94 (+2.97%) ▲|UNH397.41-9.57 (-2.35%) ▼|UNP307.49+3.49 (+1.15%) ▲|UPS109.57+1.32 (+1.22%) ▲|USB60.52+1.07 (+1.80%) ▲|V426.08+12.49 (+3.02%) ▲|VZ44.94+0.21 (+0.46%) ▲|WFC84.96+1.56 (+1.86%) ▲|WMT126.97+3.46 (+2.80%) ▲|XOM180.46-6.79 (-3.63%) ▼|AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.90+3.70 (+3.48%) ▲|ACN262.81+4.57 (+1.77%) ▲|ADBE255.00+4.77 (+1.91%) ▲|AMAT387.78-2.31 (-0.59%) ▼|AMD483.88-20.93 (-4.15%) ▼|AMGN466.59+0.58 (+0.12%) ▲|AMT188.18+0.40 (+0.21%) ▲|AMZN250.14+9.79 (+4.07%) ▲|AVGO329.94+3.86 (+1.18%) ▲|AXP328.87+9.76 (+3.06%) ▲|BA175.65+4.10 (+2.39%) ▲|BAC50.24+0.23 (+0.46%) ▲|BKNG155.04+6.91 (+4.66%) ▲|BLK1,174.62+27.08 (+2.36%) ▲|BMY62.46-0.02 (-0.03%) ▼|BNY148.30+1.19 (+0.81%) ▲|BRK-B554.76+12.27 (+2.26%) ▲|C123.82+1.85 (+1.52%) ▲|CAT623.25+0.50 (+0.08%) ▲|CL96.99+1.70 (+1.78%) ▲|CMCSA23.75+0.53 (+2.28%) ▲|COF212.07+7.22 (+3.52%) ▲|COP147.31-6.72 (-4.36%) ▼|COST1,039.22+26.94 (+2.66%) ▲|CRM232.27+3.10 (+1.35%) ▲|CSCO103.19-1.32 (-1.26%) ▼|CVS88.53-1.73 (-1.91%) ▼|CVX228.15-7.37 (-3.13%) ▼|DE664.40-11.08 (-1.64%) ▼|DHR229.50-2.73 (-1.18%) ▼|DIS113.60+2.66 (+2.40%) ▲|DUK127.93+0.54 (+0.42%) ▲|EMR168.41+3.47 (+2.10%) ▲|FDX319.72+6.44 (+2.06%) ▲|GD369.31-3.29 (-0.88%) ▼|GE315.95+14.15 (+4.69%) ▲|GEV877.20+19.33 (+2.25%) ▲|GILD170.19-0.49 (-0.29%) ▼|GM89.40+2.00 (+2.28%) ▲|GOOG281.97+3.75 (+1.35%) ▲|GOOGL283.48+3.64 (+1.30%) ▲|GS909.74+15.19 (+1.70%) ▲|HD339.46+10.26 (+3.12%) ▲|HON225.16+6.83 (+3.13%) ▲|IBM258.34+0.53 (+0.21%) ▲|INTC61.96-3.81 (-5.79%) ▼|INTU355.56+14.47 (+4.24%) ▲|ISRG444.94+12.93 (+2.99%) ▲|JNJ269.26-3.94 (-1.44%) ▼|JPM341.71+4.67 (+1.38%) ▲|KO95.69+1.61 (+1.71%) ▲|LIN521.96+7.72 (+1.50%) ▲|LLY1,412.61-4.93 (-0.35%) ▼|LMT641.11+4.16 (+0.65%) ▲|LOW216.26+7.19 (+3.44%) ▲|LRCX232.86-6.25 (-2.61%) ▼|MA659.63+21.62 (+3.39%) ▲|MCD263.87+5.75 (+2.23%) ▲|MDLZ66.05+1.11 (+1.70%) ▲|MDT98.69+2.15 (+2.23%) ▲|META612.09-2.90 (-0.47%) ▼|MMM179.35+5.01 (+2.87%) ▲|MO77.51-0.52 (-0.67%) ▼|MRK148.53-0.99 (-0.66%) ▼|MS186.52+2.22 (+1.20%) ▲|MSFT520.02-1.90 (-0.36%) ▼|MU852.74-32.00 (-3.62%) ▼|NEE84.99+1.28 (+1.52%) ▲|NFLX62.60+0.52 (+0.84%) ▲|NKE39.53+0.86 (+2.22%) ▲|NOW108.78+3.66 (+3.48%) ▲|NVDA206.58+1.94 (+0.95%) ▲|ORCL122.29-8.38 (-6.41%) ▼|PEP140.01+2.67 (+1.94%) ▲|PFE30.71+0.19 (+0.61%) ▲|PG163.79+2.22 (+1.37%) ▲|PLTR184.31+0.20 (+0.11%) ▲|PM208.04-0.75 (-0.36%) ▼|QCOM166.20+1.41 (+0.86%) ▲|RTX201.84+2.04 (+1.02%) ▲|SBUX103.86+0.21 (+0.20%) ▲|SCHW89.25+1.20 (+1.36%) ▲|SO94.31+0.60 (+0.64%) ▲|SPG222.83+5.08 (+2.33%) ▲|T21.44+0.03 (+0.14%) ▲|TMO685.44-11.56 (-1.66%) ▼|TMUS158.56+2.12 (+1.36%) ▲|TSLA408.55+8.74 (+2.18%) ▲|TXN308.30+7.46 (+2.48%) ▲|UBER67.19+1.94 (+2.97%) ▲|UNH397.41-9.57 (-2.35%) ▼|UNP307.49+3.49 (+1.15%) ▲|UPS109.57+1.32 (+1.22%) ▲|USB60.52+1.07 (+1.80%) ▲|V426.08+12.49 (+3.02%) ▲|VZ44.94+0.21 (+0.46%) ▲|WFC84.96+1.56 (+1.86%) ▲|WMT126.97+3.46 (+2.80%) ▲|XOM180.46-6.79 (-3.63%) ▼|
19.6 C
New York
Monday, November 2, 2026

Tag: Medtronic plc

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Directors bring expertise across healthcare access, medtech, commercial operations, manufacturing and public-company governance as MiniMed begins its next chapter as an independent company focused...

Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable

Annual list recognizes inventions making the world better and smarterGALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by...

SHERIDAN, Wyo., Oct. 6, 2026 /PRNewswire/ -- The global drug delivery devices market is projected to grow from USD 488.6 billion in 2026 to USD...

Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by...

SHERIDAN, Wyo., Oct. 6, 2026 /PRNewswire/ -- The global drug delivery devices market is projected to grow from USD 488.6 billion in 2026 to USD...

[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Artivion Inc., Athersys Inc., Baxter International Inc., Cellular Logistics Inc., Elutia Inc., Heartseed Inc., Medtronic Plc, Merck kGaA, Mesoblast Ltd., Neoolife Inc., Tejiin Limited, Terumo Corporation, and W.L. Gore & Associates, Inc and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Artivion Inc., Athersys Inc., Baxter International Inc., Cellular Logistics Inc., Elutia Inc., Heartseed Inc., Medtronic Plc, Merck kGaA, Mesoblast Ltd., Neoolife Inc., Tejiin Limited, Terumo Corporation, and W.L. Gore & Associates, Inc and others.

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy,...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in...

Studies show promising results for individuals with type 2 diabetes and young children with type 1 diabetes on MiniMed™ 780G system

Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology. GALWAY, Ireland and...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedtronic plc